WHO, 07 July 2017 Every day, more than 1 million sexually transmitted infections are acquired worldwide, and each year an estimated 78 million people are infected with gonorrhoea. New data from 77 countries show that antibiotic resistance is making gonorrhoea much harder – and sometimes impossible – to treat. The data has been published in PLOS, in two new scientific articles. Read more...
The Age, Published APRIL 2 2017 Doctors are on the cusp of launching the first new male contraceptive in more than a century. But rather than a Big Pharma lab, the breakthrough is emerging from a university start-up in the heart of rural India. Years of human trials on the injectable, sperm-zapping product are coming to an end, and researchers are preparing to submit it for regulatory approval...
SHine SA, October 2016 SHine SA and Family Planning Alliance Australia put in submissions to the TGA for the rescheduling of ulipristal acetate (EllaOne®), a new emergency contraceptive pill in Australia. The rescheduling is from prescription-only to Schedule 3 (available in pharmacies with a pharmacy consultation). This has now been approved, to take place from February 2017. This is an...
It Takes Two: How Men Fit into Expanding the Family Planning Method Mix Contraceptive Technology Innovation (CTI) Exchange, July 5, 2016 9:22 am The terms “family planning” and “birth control” are synonymous with women’s health and associated with the struggle for equal rights and women’s liberation. And while the advent of the pill and subsequent advances in contraceptive technology have had...
Slate, Sept. 2 2016 1:07 PM For many gay and bi men, it’s a perennial point of contention: Are “minor” sexually transmitted infections—like chlamydia or gonorrhea—a cause for serious concern or major behavior modification? A recent study by the Centers for Disease Control and Prevention, featured in its Morbidity and Mortality Weekly Report, found a significant rise in resistance to one of the...
Australian Federation of AIDS Organisations (AFAO), 23 August, 2016 Following the Pharmaceutical Benefits Advisory Committee (PBAC) decision not to recommend funding PrEP through the Pharmaceutical Benifits Scheme (PBS), AFAO has produced an Australian PrEP roundup paper to sustain advocacy efforts and to raise awareness about current options for accessing PrEP around the country. In releasing...